Bepirovirsen added to standard-of-care medications led to higher functional cure rates for people with chronic hepatitis B than standard…
Articles by Marisa Wexler, MS
Madrigal Pharmaceuticals, the maker of Rezdiffra (resmetiron), has acquired three new experimental treatments for metabolic dysfunction-associated steatohepatitis (MASH), a…
Health Canada has expanded its approval of Abbvie’s oral therapy Maviret (glecaprevir/pibrentasvir), making it the first eight-week, pan-genotypic treatment…
About one year of treatment with Altimmune’s experimental therapy pemvidutide led to reductions in noninvasive markers of liver scarring…
Throughout 2025, the team at Liver Disease News has reported on the latest research and advances in care related to…
Researchers in the U.S. have developed a rapid point-of-care test that detects active hepatitis C infection by identifying HCV…
About half of children with progressive familial intrahepatic cholestasis (PFIC) were found to have cirrhotic cardiomyopathy (CCM), a form…
The U.S. Food and Drug Administration (FDA) has authorized the use of the first artificial intelligence (AI) drug-development tool for…
Using a minimally invasive method called laparoscopy to conduct standard Kasai surgery significantly reduces blood loss and increases the chances…
Major medical associations and state health departments are moving to maintain the standard of universal hepatitis B vaccination at…